34 related articles for article (PubMed ID: 38461123)
1. Palliative care needs among outpatient adults with cystic fibrosis: Baseline data from the Improving Life with CF trial.
DiFiglia S; Georgiopoulos AM; Portenoy R; Seng E; Berdella M; Friedman D; Kier C; Linnemann RW; Middour-Oxler B; Walker P; Wang J; Yonker LM; Buehler B; Chaudhary N; Esposito C; Frantzen T; Henthorne K; Plachta A; Pollinger S; Stables-Carney T; Trentacoste J; Dhingra L
J Cyst Fibros; 2023 Nov; ():. PubMed ID: 37951787
[TBL] [Abstract][Full Text] [Related]
2. Self-reported physical and psychological symptom burden in adults with cystic fibrosis.
Sawicki GS; Sellers DE; Robinson WM
J Pain Symptom Manage; 2008 Apr; 35(4):372-80. PubMed ID: 18215497
[TBL] [Abstract][Full Text] [Related]
3. Integrating specialist palliative care to improve care and reduce suffering: cystic fibrosis (InSPIRe:CF) - study protocol for a multicentre randomised clinical trial.
Lowers J; Dellon EP; Stephenson A; Arnold R; Althouse A; Jeong K; Dubin E; Soodalter J; Hovater C; Bakitas M; Goggin J; Hunt W; Ladores S; Curseen K; Winter G; Solomon G; Ailon J; Conrad D; Kavalieratos D
BMJ Open Respir Res; 2022 Sep; 9(1):. PubMed ID: 36126995
[TBL] [Abstract][Full Text] [Related]
4. Effects of a primary palliative care intervention on quality of life and mental health in cystic fibrosis.
Friedman D; Linnemann RW; Altstein LL; Georgiopoulos AM; Islam S; Bach KT; St John A; Fracchia MS; Neuringer I; Lapey A; Sicilian L; Moskowitz SM; Yonker LM
Pediatr Pulmonol; 2019 Jul; 54(7):984-992. PubMed ID: 30854795
[TBL] [Abstract][Full Text] [Related]
5. Symptoms and quality of life in adults with cystic fibrosis: A cross-sectional analysis of the InSPIRe:CF trial.
Smirnova N; Lowers J; Cammarata-Mouchtouris A; Dellon EP; Fitzpatrick A; Kavalieratos D
J Cyst Fibros; 2024 Mar; ():. PubMed ID: 38461123
[TBL] [Abstract][Full Text] [Related]
6. Addressing Symptom Burden and Palliative Care Needs in Cystic Fibrosis: A Narrative Review of the Literature.
DiFiglia S; Dhingra L; Georgiopoulos AM; Papia K; Sullivan E; Plachta A; Boccio C; Portenoy R; Basile M
Life (Basel); 2023 Jul; 13(8):. PubMed ID: 37629478
[TBL] [Abstract][Full Text] [Related]
7. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
8. Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.
Green J; Gilchrist FJ; Carroll W
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012619. PubMed ID: 29894558
[TBL] [Abstract][Full Text] [Related]
9. Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.
Carroll W; Green J; Gilchrist FJ
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD012619. PubMed ID: 34936085
[TBL] [Abstract][Full Text] [Related]
10. Exercise versus airway clearance techniques for people with cystic fibrosis.
Heinz KD; Walsh A; Southern KW; Johnstone Z; Regan KH
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013285. PubMed ID: 35731672
[TBL] [Abstract][Full Text] [Related]
11. Nebulised hypertonic saline for cystic fibrosis.
Wark P; McDonald VM
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
